Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9297195Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Anatomy & Cell Biology
NIH Funding · FY2026
Linked Award Amount
$3.8M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#974
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Kevin Sean Murnane as a PI. Multi-PI records show the full award amount for context.
- 5UG3DA061709-02UG3IND-enabling studies and phase I clinical trials to advance CD74-target, DRhQ, as a treatment for stimulant use disorder$3.3Maward amount
- 5R01DA061433-03R01Investigations into 5-HT2A signaling mechanisms of psychedelic drugs for the treatment of stimulant use disorder$480.5Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Kevin Sean Murnane as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardVirogenomics Biodevelopment, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9942
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #1874
- 2025Entered Top 10% NationallyRanked #1874
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026Entered Top 5% NationallyRanked #974
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Kevin Sean Murnane.